Key facts
- Augmentive’s last known valuation is $8.8M (Feb 2025).
- It has raised $3.3M; the latest was Seed Round ($1.2M) in Feb 2025.
- Notable investors include Cambridge Angels, Venrex Investment Management, Lyka.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Augmentive
- ·The full record, as it builds
Funding rounds
No funding rounds for Augmentive are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Augmentive
Developer of a mental health care platform designed to offer quick access to certified therapists, coaches, psychiatrists, and holistic specialists. The company's software employs artificial intelligence and automation to deliver health and well-being services through qualified professionals, enabling businesses to obtain psychological support for their employees at their convenience and time.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2020
- Employees
- 34
- Website
- augmentive.io/
- Ownership
- Privately Held (backing)
Augmentive doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Augmentive shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Augmentive in its N-PORT filings yet. We sweep new filings monthly.